Trial Profile
A Study to Evaluate the Definitive Bioequivalence of SCH 900068 With Marketed Products (Protocol No. P07551)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Atorvastatin/ezetimibe (Primary) ; Atorvastatin; Ezetimibe
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Organon
- 16 Oct 2012 Lead trial center changed as reported by ClinicalTrials.gov.
- 16 Jan 2012 Actual patient no changed from 40 to 200 as reported by ClinicalTrials.gov.
- 21 Dec 2011 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.